Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

ASCO 2020 Virtual Meeting/May 29-31, 2020
EHA 2020 Virtual Meeting/June 11-21, 2020
Listen to Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss the implications of recent trial results in CLL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA).
John Allan, MD
Jennifer R. Brown, MD, PhD
Released: August 26, 2020

In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). Studies and topics include:

  • ASCEND: acalabrutinib vs idelalisib plus rituximab or BR
  • ACE-CL-001: acalabrutinib long-term efficacy
  • CLL14: Venetoclax plus obinutuzumab
  • CLARITY: Ibrutinib plus venetoclax
  • Measurable residual disease (MRD)
  • Complex karyotypes
  • Zanubrutinib plus obinutuzumab and venetoclax

Content based on an online CME program supported by an educational grant from AstraZeneca.

Link to full program: https://www.clinicaloptions.com/oncology/conference-coverage/global-asco-eha-2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

Download this slideset to review the latest clinical data informing optimal management strategies for follicular lymphoma

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Download this ExpressPoints slideset for a quick summary of the latest clinical data informing optimal management of follicular lymphoma

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Commentary from Guy Young, MD, on selecting foundational vs emerging treatment options for hemophilia A, presented by Clinical Care Options (CCO)

Guy A. Young, MD Released: October 14, 2020

CCO printable treatment algorithm and toxicity management table to help optimize care of your patients with follicular lymphoma

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Released: September 30, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue